By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Startup molecular diagnostics firm PathoGene announced today it has raised $750,000 in its first round of financing.
The company had targeted $500,000, it added. It did not specify how the money will be used.
Registering provides access to this and other free content.
Already have an account?Login Now.
The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.
In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.
Stanford University researchers are studying top athletes to uncover genes linked to performance.
In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.
This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.